메뉴 건너뛰기




Volumn 66, Issue 2, 2014, Pages 243-249

CYP2C9, VKORC1, CYP4F2, ABCB1 and F5 variants: Influence on quality of long-term anticoagulation

Author keywords

Acenocoumarol; Anticoagulation; Genetic; India; Warfarin

Indexed keywords

ACENOCOUMAROL; CYTOCHROME P450 2C9; MULTIDRUG RESISTANCE PROTEIN 1; WARFARIN; ABCB1 PROTEIN, HUMAN; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5 LEIDEN; CYP2C9 PROTEIN, HUMAN; CYP4F2 PROTEIN, HUMAN; CYTOCHROME P450; MULTIDRUG RESISTANCE PROTEIN; VITAMIN K EPOXIDE REDUCTASE; VKORC1 PROTEIN, HUMAN;

EID: 84899629832     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/j.pharep.2013.09.006     Document Type: Article
Times cited : (13)

References (52)
  • 1
    • 0034958124 scopus 로고    scopus 로고
    • Fenofibrate and warfarin interaction
    • Aldridge MA, Ito MK. Fenofibrate and warfarin interaction. Pharmacotherapy 2001;21(7):886-9. (Pubitemid 32606803)
    • (2001) Pharmacotherapy , vol.21 , Issue.7 , pp. 886-889
    • Aldridge, M.A.1    Ito, M.K.2
  • 2
    • 29144471067 scopus 로고    scopus 로고
    • Interactions between thrombophilic genetic mutations and clinical bleeding in patients on chronic oral anticoagulant treatment
    • Castori L, Taliani MR, Agnelli G, Boschetti E, Gresele P. Interactions between thrombophilic genetic mutations and clinical bleeding in patients on chronic OAC treatment. Haematologica 2005;90(12):1720-2. (Pubitemid 41815009)
    • (2005) Haematologica , vol.90 , Issue.12 , pp. 1720-1722
    • Castori, L.1    Taliani, M.R.2    Agnelli, G.3    Boschetti, E.4    Gresele, P.5
  • 3
    • 77954508907 scopus 로고    scopus 로고
    • CYP4F2 rs2108622: A minor significant genetic factor of warfarin dose in Han Chinese patients with mechanical heart valve replacement
    • Cen HJ, Zeng WT, Leng XY, Huang M, Chen X, Li JL, et al. CYP4F2 rs2108622: a minor significant genetic factor of warfarin dose in Han Chinese patients with mechanical heart valve replacement. Br J Clin Pharmacol 2010;70(2):234-40.
    • (2010) Br J Clin Pharmacol. , vol.70 , Issue.2 , pp. 234-240
    • Cen, H.J.1    Zeng, W.T.2    Leng, X.Y.3    Huang, M.4    Chen, X.5    Li, J.L.6
  • 4
    • 0033809508 scopus 로고    scopus 로고
    • Effect of niacin, warfarin, and antioxidant therapy on coagulation parameters in patients with peripheral arterial disease in the Arterial Disease Multiple Intervention Trial (ADMIT)
    • Chesney CM, Elam MB, Herd JA, Davis KB, Garg R, Hunninghake D, et al. Effect of niacin, warfarin, and antioxidant therapy on coagulation parameters in patients with peripheral arterial disease in the Arterial Disease Multiple Intervention Trial (ADMIT). Am Heart 2000;140(4):631-6.
    • (2000) Am Heart. , vol.140 , Issue.4 , pp. 631-636
    • Chesney, C.M.1    Elam, M.B.2    Herd, J.A.3    Davis, K.B.4    Garg, R.5    Hunninghake, D.6
  • 5
    • 0035098515 scopus 로고    scopus 로고
    • Increase in international normalized ratio associated with smoking cessation [1]
    • Colucci VJ, Knapp JF. Increase in international normalized ratio associated with smoking cessation. Ann Pharmacother 2001;35(3):385-6. (Pubitemid 32201727)
    • (2001) Annals of Pharmacotherapy , vol.35 , Issue.3 , pp. 385-386
    • Colucci, V.J.1
  • 6
    • 0028670856 scopus 로고
    • Reduction of vitamin K2 concentrations in human liver associated with the use of broad spectrum antimicrobials
    • Conly J, Stein K. Reduction of vitamin K2 concentrations in human liver associated with the use of broad spectrum antimicrobials. Clin Invest Med 1994;17:531-9.
    • (1994) Clin Invest Med. , vol.17 , pp. 531-539
    • Conly, J.1    Stein, K.2
  • 10
    • 0037320652 scopus 로고    scopus 로고
    • Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor
    • DOI 10.1093/hmg/ddg055
    • Duan J, Wainwright MS, Comeron JM, Saitou N, Sanders AR, Gelernter J, et al. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet 2003;12(3): 205-16. (Pubitemid 36204418)
    • (2003) Human Molecular Genetics , vol.12 , Issue.3 , pp. 205-216
    • Duan, J.1    Wainwright, M.S.2    Comeron, J.M.3    Saitou, N.4    Sanders, A.R.5    Gelernter, J.6    Gejman, P.V.7
  • 11
    • 27644562751 scopus 로고    scopus 로고
    • Increase in international normalized ratio after smoking cessation in a patient receiving warfarin
    • DOI 10.1592/phco.2005.25.11.1656
    • Evans M, Lewis GM. Increase in international normalized ratio after smoking cessation in a patient receiving warfarin. Pharmacotherapy 2005;25(11):1656-9. (Pubitemid 41566925)
    • (2005) Pharmacotherapy , vol.25 , Issue.11 , pp. 1656-1659
    • Evans, M.1    Lewis, G.M.2
  • 12
    • 33344461585 scopus 로고    scopus 로고
    • Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF)
    • DOI 10.1016/j.ahj.2005.04.017, PII S0002870305004369
    • Gage BF, Yan Y, Milligan PE, Waterman AD, Culverhouse R, Rich MW, et al. Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J 2006;151(3):713-9. (Pubitemid 43290267)
    • (2006) American Heart Journal , vol.151 , Issue.3 , pp. 713-719
    • Gage, B.F.1    Yan, Y.2    Milligan, P.E.3    Waterman, A.D.4    Culverhouse, R.5    Rich, M.W.6    Radford, M.J.7
  • 13
    • 84877146316 scopus 로고    scopus 로고
    • Identification and weighting of the most critical ''real-life'' drug-drug interactions with acenocoumarol in a tertiary care hospital
    • Gschwind L, Rollason V, Lovis C, Boehlen F, Bonnabry P, Dayer P, et al. Identification and weighting of the most critical ''real-life'' drug-drug interactions with acenocoumarol in a tertiary care hospital. Eur J Clin Pharmacol 2013;69(3):617-27.
    • (2013) Eur J Clin Pharmacol. , vol.69 , Issue.3 , pp. 617-627
    • Gschwind, L.1    Rollason, V.2    Lovis, C.3    Boehlen, F.4    Bonnabry, P.5    Dayer, P.6
  • 15
    • 59549094940 scopus 로고    scopus 로고
    • Effect of CYP2C9 and VKORC1 genotypes on early-phase and steady-state warfarin dosing in Korean patients with mechanical heart valve replacement
    • Kim HS, Lee SS, Oh M, Jang YJ, Kim EY, Han IY, et al. Effect of CYP2C9 and VKORC1 genotypes on early-phase and steady-state warfarin dosing in Korean patients with mechanical heart valve replacement. Pharmacogenet Genomics 2009;19(2):103-12.
    • (2009) Pharmacogenet Genomics. , vol.19 , Issue.2 , pp. 103-112
    • Kim, H.S.1    Lee, S.S.2    Oh, M.3    Jang, Y.J.4    Kim, E.Y.5    Han, I.Y.6
  • 19
    • 84866706420 scopus 로고    scopus 로고
    • Correlation between single nucleotide polymorphisms in CYP4F2 and warfarin dosing in Chinese valve replacement patients
    • Li JH, Ma GG, Zhu SQ, Yan H, Wu YB, Xu JJ. Correlation between single nucleotide polymorphisms in CYP4F2 and warfarin dosing in Chinese valve replacement patients. J Cardiothorac Surg 2012;7:97.
    • (2012) J Cardiothorac Surg. , vol.7 , pp. 97
    • Li, J.H.1    Ma, G.G.2    Zhu, S.Q.3    Yan, H.4    Wu, Y.B.5    Xu, J.J.6
  • 20
    • 84899623426 scopus 로고    scopus 로고
    • Impact of CYP2C9 and VKORC1 polymorphism on warfarin response during initiation of therapy
    • Liu Y, Zhong SL, Tan HH, Yang M, Fei HW, Yu XY, et al. Impact of CYP2C9 and VKORC1 polymorphism on warfarin response during initiation of therapy. Zhonghua Xin Xue Guan Bing Za Zhi 2011;39(10):929-35.
    • (2011) Zhonghua Xin Xue Guan Bing Za Zhi. , vol.39 , Issue.10 , pp. 929-935
    • Liu, Y.1    Zhong, S.L.2    Tan, H.H.3    Yang, M.4    Fei, H.W.5    Yu, X.Y.6
  • 21
    • 84875260950 scopus 로고    scopus 로고
    • Influence of warfarin doseassociated genotypes on the risk of hemorrhagic complications in Chinese patients on warfarin
    • Ma C, Zhang Y, Xu Q, Yang J, Zhang Y, Gao L, et al. Influence of warfarin doseassociated genotypes on the risk of hemorrhagic complications in Chinese patients on warfarin. Int J Hematol 2012;96(6):719-28.
    • (2012) Int J Hematol. , vol.96 , Issue.6 , pp. 719-728
    • Ma, C.1    Zhang, Y.2    Xu, Q.3    Yang, J.4    Zhang, Y.5    Gao, L.6
  • 23
    • 65249102147 scopus 로고    scopus 로고
    • Novel variants of major drug-metabolising enzyme genes in diverse African populations and their predicted functional effects
    • Matimba A, Del-Favero J, Van Broeckhoven C, Masimirembwa C. Novel variants of major drug-metabolising enzyme genes in diverse African populations and their predicted functional effects. Hum Genomics 2009;3(2):169-90.
    • (2009) Hum Genomics. , vol.3 , Issue.2 , pp. 169-190
    • Matimba, A.1    Del-Favero, J.2    Van Broeckhoven, C.3    Masimirembwa, C.4
  • 24
    • 66849132349 scopus 로고    scopus 로고
    • CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variant
    • McDonald MG, Rieder MJ, Nakano M, Hsia CK, Rettie AE. CYP4F2 is a vitamin K1 oxidase: an explanation for altered warfarin dose in carriers of the V433M variant. Mol Pharmacol 2009 75 6 1337-1346.
    • (2009) Mol Pharmacol. , vol.75 , Issue.6 , pp. 1337-1346
    • McDonald, M.G.1    Rieder, M.J.2    Nakano, M.3    Hsia, C.K.4    Rettie, A.E.5
  • 27
    • 33746613172 scopus 로고    scopus 로고
    • Main haplotypes and mutational analysis of vitamin K epoxide reductase (VKORC1) in a Swedish population: A retrospective analysis of case records
    • DOI 10.1111/j.1538-7836.2006.02039.x
    • Osman A, EnströmC, Arbring K, Sö derkvist P, Lindahl TL. Main haplotypes and mutational analysis of vitamin K epoxide reductase (VKORC1) in a Swedish population: a retrospective analysis of case records. J Thromb Haemost 2006;4(8):1723-9. (Pubitemid 44144799)
    • (2006) Journal of Thrombosis and Haemostasis , vol.4 , Issue.8 , pp. 1723-1729
    • Osman, A.1    Enstrom, C.2    Arbring, K.3    Soderkvist, P.4    Lindahl, T.L.5
  • 28
    • 79952176479 scopus 로고    scopus 로고
    • Interactions between natural health products and oral anticoagulants: Spontaneous reports in the Italian Surveillance System of Natural Health Products
    • Paoletti A, Gallo E, Benemei S, Vietri M, Lapi F, Volpi R, et al. Interactions between natural health products and oral anticoagulants: spontaneous reports in the Italian Surveillance System of Natural Health Products. Evid Based Complement Alternat Med 2011;2011:612150.
    • (2011) Evid Based Complement Alternat Med. , vol.2011 , pp. 612150
    • Paoletti, A.1    Gallo, E.2    Benemei, S.3    Vietri, M.4    Lapi, F.5    Volpi, R.6
  • 29
    • 72849127064 scopus 로고    scopus 로고
    • Genetic factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) are predictor variables for warfarin response in very elderly, frail inpatients
    • Pautas E, Moreau C, Gouin-Thibault I, Golmard JL, Mahé I, Legendre C, et al. Genetic factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) are predictor variables for warfarin response in very elderly, frail inpatients. Clin Pharmacol Ther 2010;87(1):57-64.
    • (2010) Clin Pharmacol Ther. , vol.87 , Issue.1 , pp. 57-64
    • Pautas, E.1    Moreau, C.2    Gouin-Thibault, I.3    Golmard, J.L.4    Mahé, I.5    Legendre, C.6
  • 30
    • 38349134238 scopus 로고    scopus 로고
    • Risk of major bleeding during concomitant use of antibiotic drugs and coumarin anticoagulants
    • Penning-van Beest FJ, Koerselman J, Herings RM. Risk of major bleeding during concomitant use of antibiotic drugs and coumarin anticoagulants. J Thromb Haemost 2008;6(2):284-90.
    • (2008) J Thromb Haemost. , vol.6 , Issue.2 , pp. 284-290
    • Penning-Van Beest, F.J.1    Koerselman, J.2    Herings, R.M.3
  • 31
    • 0034979678 scopus 로고    scopus 로고
    • Drug interactions as a cause of overanticoagulation on phenprocoumon or acenocoumarol predominantly concern antibacterial drugs
    • DOI 10.1067/mcp.2001.115723
    • Penning-van Beest FJ, van Meegen E, Rosendaal FR, Stricker BH. Drug interactions as a cause of overanticoagulation on phenprocoumon or acenocoumarol predominantly concern antibacterial drugs. Clin Pharmacol Ther 2001;69(6):451-7. (Pubitemid 32554551)
    • (2001) Clinical Pharmacology and Therapeutics , vol.69 , Issue.6 , pp. 451-457
    • Penning-Van Beest, F.J.A.1    Van Meegen, E.2    Rosendaal, F.R.3    Stricker, B.H.4
  • 33
    • 0028210729 scopus 로고
    • Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9
    • Rettie AE, Wienkers LC, Gonzalez FJ, Trager WF, Korzekwa KR. Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9. Pharmacogenetics 1994;4:39-42. (Pubitemid 24106122)
    • (1994) Pharmacogenetics , vol.4 , Issue.1 , pp. 39-42
    • Rettie, A.E.1    Wienkers, L.C.2    Gonzalez, F.J.3    Trager, W.F.4    Korzekwa, K.R.5
  • 34
    • 78649342646 scopus 로고    scopus 로고
    • Patient characteristics associated with oral anticoagulation control: Results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA)
    • Rose AJ, Hylek EM, Ozonoff A, Ash AS, Reisman JI, Berlowitz DR. Patient characteristics associated with oral anticoagulation control: results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA). J Thromb Haemost 2010;8(10):2182-91.
    • (2010) J Thromb Haemost. , vol.8 , Issue.10 , pp. 2182-2191
    • Rose, A.J.1    Hylek, E.M.2    Ozonoff, A.3    Ash, A.S.4    Reisman, J.I.5    Berlowitz, D.R.6
  • 35
    • 36248936550 scopus 로고    scopus 로고
    • Pharmacogenetics of acenocoumarol: CYP2C9, CYP2C19, CYP1A2, CYP3A4, CYP3A5 and ABCB1 gene polymorphisms and dose requirements
    • DOI 10.1111/j.1365-2710.2007.00870.x
    • Saraeva RB, Paskaleva ID, Doncheva E, Eap CB, Ganev VS. Pharmacogenetics of acenocoumarol: CYP2C9, CYP2C19, CYP1A2, CYP3A4, CYP3A5 and ABCB1 gene polymorphisms and dose requirements. J Clin Pharm Ther 2007;32(6):641-9. (Pubitemid 350135117)
    • (2007) Journal of Clinical Pharmacy and Therapeutics , vol.32 , Issue.6 , pp. 641-649
    • Saraeva, R.B.1    Paskaleva, I.D.2    Doncheva, E.3    Eap, C.B.4    Ganev, V.S.5
  • 38
    • 33751255101 scopus 로고    scopus 로고
    • Development of a contemporary bleeding risk model for elderly warfarin recipients
    • DOI 10.1378/chest.130.5.1390
    • Shireman TI, Mahnken JD, Howard PA, Kresowik TF, Hou Q, Ellerbeck EF. Development of a contemporary bleeding risk model for elderly warfarin recipients. Chest 2006;130:1390-6. (Pubitemid 44786731)
    • (2006) Chest , vol.130 , Issue.5 , pp. 1390-1396
    • Shireman, T.I.1    Mahnken, J.D.2    Howard, P.A.3    Kresowik, T.F.4    Hou, Q.5    Ellerbeck, E.F.6
  • 39
    • 55449133425 scopus 로고    scopus 로고
    • Effects of CYP2C9 and VKORC1 on INR variations and dose requirements during initial phase of anticoagulant therapy
    • Spreafico M, Lodigiani C, van Leeuwen Y, Pizzotti D, Rota LL, Rosendaal F, et al. Effects of CYP2C9 and VKORC1 on INR variations and dose requirements during initial phase of anticoagulant therapy. Pharmacogenomics 2008;9(9):1237-50.
    • (2008) Pharmacogenomics. , vol.9 , Issue.9 , pp. 1237-1250
    • Spreafico, M.1    Lodigiani, C.2    Van Leeuwen, Y.3    Pizzotti, D.4    Rota, L.L.5    Rosendaal, F.6
  • 42
    • 29244466817 scopus 로고    scopus 로고
    • Comparative pharmacokinetics of vitamin K antagonists warfarin, phenprocoumon and acenocoumarol
    • DOI 10.2165/00003088-200544120-00003
    • Ufer M. Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol. Clin Pharmacokinet 2005;44(12):1227-46. (Pubitemid 41832565)
    • (2005) Clinical Pharmacokinetics , vol.44 , Issue.12 , pp. 1227-1246
    • Ufer, M.1
  • 45
    • 80051512500 scopus 로고    scopus 로고
    • Loading and maintenance dose algorithms for phenprocoumon and acenocoumarol using patient characteristics and pharmacogenetic data
    • van Schie RM, Wessels JA, le Cessie S, de Boer A, Schalekamp T, van der Meer FJ, et al. Loading and maintenance dose algorithms for phenprocoumon and acenocoumarol using patient characteristics and pharmacogenetic data. Eur Heart J 2011;32(15):1909-17.
    • (2011) Eur Heart J. , vol.32 , Issue.15 , pp. 1909-1917
    • Van Schie, R.M.1    Wessels, J.A.2    Le Cessie, S.3    De Boer, A.4    Schalekamp, T.5    Van Der Meer, F.J.6
  • 47
    • 59649117935 scopus 로고    scopus 로고
    • The largest prospective warfarin-treated cohort supports genetic forecasting
    • Wadelius M, Chen LY, Lindh JD, Eriksson N, Ghori MJ, Bumpstead S, et al. The largest prospective warfarin-treated cohort supports genetic forecasting. Blood 2009;113(4):784-92.
    • (2009) Blood. , vol.113 , Issue.4 , pp. 784-792
    • Wadelius, M.1    Chen, L.Y.2    Lindh, J.D.3    Eriksson, N.4    Ghori, M.J.5    Bumpstead, S.6
  • 48
    • 25144433260 scopus 로고    scopus 로고
    • Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability
    • Wang D, Johnson AD, Papp AC, Kroetz DL, Sadée W. Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435CT affects mRNA stability. Pharmacogenet Genomics 2005;15(10):693-704. (Pubitemid 41345321)
    • (2005) Pharmacogenetics and Genomics , vol.15 , Issue.10 , pp. 693-704
    • Wang, D.1    Johnson, A.D.2    Papp, A.C.3    Kroetz, D.L.4    Sadee, W.5
  • 49
    • 44949092499 scopus 로고    scopus 로고
    • India: Country Profile.
    • WHO Report on the Global Tobacco Epidemic. India: Country Profile; 2011, Available online at: http://www.who.int/tobacco/surveillance/policy/ countryprofile/ind.pdf (accessed 24.04.13).
    • (2011) WHO Report on the Global Tobacco Epidemic
  • 50
    • 0035192049 scopus 로고    scopus 로고
    • Drug interactions update: Drugs, herbs, and oral anticoagulation
    • DOI 10.1023/A:1012742628628
    • Wittkowsky AK. Drug interactions update: drugs, herbs, and oral anticoagulation. J Thromb Thrombolysis 2001;12(1):67-71. (Pubitemid 33103844)
    • (2001) Journal of Thrombosis and Thrombolysis , vol.12 , Issue.1 , pp. 67-71
    • Wittkowsky, A.K.1
  • 51
    • 3042737049 scopus 로고    scopus 로고
    • Brief communication: American ginseng reduces warfarin's effect in healthy patients: A randomized, controlled Trial
    • Yuan CS, Wei G, Dey L, Karrison T, Nahlik L, Maleckar S, et al. Brief communication: American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled Trial. Ann Intern Med 2004;141(1):23-7.
    • (2004) Ann Intern Med. , vol.141 , Issue.1 , pp. 23-27
    • Yuan, C.S.1    Wei, G.2    Dey, L.3    Karrison, T.4    Nahlik, L.5    Maleckar, S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.